🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the Pharmacokinetics of Danoprevir...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT03019991
Treatments Being Tested
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
This randomized, double blind, phase II study will evaluate the efficacy an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01579019
Treatments Being Tested
This is a multi-center, open-label clinical study. This study was aimed to ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-03-30
Trial ID
NCT03887637
Treatments Being Tested
This randomized, open-label, active-controlled, parallel-group study will e...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01220947
Treatments Being Tested
This multicenter, randomized, double-blind, parallel group study will evalu...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01278134
This single-dose, randomized, open-label, 2-sequence, 3-period study will e...
Status
Completed
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01514968
Treatments Being Tested
This open-label, multiple dose, single sequence crossover study will evalua...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01531647
Treatments Being Tested
This phase 1, randomized, open-label, multiple-dose, 2-sequence, 2-period c...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01588002
Treatments Being Tested
Evaluation of the efficacy and safety of Danoprevir sodium tablet combined ...
Status
Completed
Location
Huoshenshan Hostipal
Start Date
2020-03-18
Trial ID
NCT04345276
Treatments Being Tested